To further evaluate MYC-RIBOTAC in other relevant tumour cell lines, the human Burkitt lymphoma cell lines Namalwa and Raji and the leukaemia cell line HL-60 were tested, in which MYC is overexpressed due to translocations or amplification. This evidence concerns the gene MYC and Burkitt lymphoma.